
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1248707
[patent_doc_number] => 06673907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-06
[patent_title] => 'Methods and compositions for the manufacture of C-3 and C-4 anthracycline antibiotics'
[patent_app_type] => B2
[patent_app_number] => 09/956588
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 44
[patent_no_of_words] => 24378
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673907.pdf
[firstpage_image] =>[orig_patent_app_number] => 09956588
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/956588 | Methods and compositions for the manufacture of C-3 and C-4 anthracycline antibiotics | Sep 18, 2001 | Issued |
Array
(
[id] => 53210
[patent_doc_number] => 07772194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Pesticidal formulations'
[patent_app_type] => utility
[patent_app_number] => 10/488076
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10520
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772194.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488076
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488076 | Pesticidal formulations | Sep 16, 2001 | Issued |
Array
(
[id] => 6674824
[patent_doc_number] => 20030060427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Local injection prescription'
[patent_app_type] => new
[patent_app_number] => 09/954513
[patent_app_country] => US
[patent_app_date] => 2001-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2007
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060427.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954513
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954513 | Local injection prescription | Sep 9, 2001 | Abandoned |
Array
(
[id] => 953975
[patent_doc_number] => 06958389
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-25
[patent_title] => 'Tetraphenylbacteriochlorin derivatives and compositions containing the same'
[patent_app_type] => utility
[patent_app_number] => 10/363824
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11536
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/958/06958389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363824 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | Sep 5, 2001 | Issued |
| 09/926118 | Erythromycin derivatives | Sep 5, 2001 | Abandoned |
Array
(
[id] => 1329155
[patent_doc_number] => 06600025
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Intermediates, process for preparing macrolide antibiotic agent therefrom'
[patent_app_type] => B1
[patent_app_number] => 09/856383
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4123
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/600/06600025.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856383
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856383 | Intermediates, process for preparing macrolide antibiotic agent therefrom | Sep 5, 2001 | Issued |
Array
(
[id] => 7678993
[patent_doc_number] => 20030195343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Process for producing erythromycin derivative'
[patent_app_type] => new
[patent_app_number] => 10/363318
[patent_app_country] => US
[patent_app_date] => 2003-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6581
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363318
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363318 | Process for producing erythromycin derivative | Aug 30, 2001 | Issued |
Array
(
[id] => 1333161
[patent_doc_number] => 06596697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-22
[patent_title] => 'Injectable ready-to-use solutions containing an antitumor anthracycline glycoside'
[patent_app_type] => B2
[patent_app_number] => 09/945539
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8249
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596697.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945539
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945539 | Injectable ready-to-use solutions containing an antitumor anthracycline glycoside | Aug 29, 2001 | Issued |
Array
(
[id] => 6797027
[patent_doc_number] => 20030175901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Polynucleotides encoding the fkbA gene of the FK-520 polyketide synthase gene cluster'
[patent_app_type] => new
[patent_app_number] => 09/940316
[patent_app_country] => US
[patent_app_date] => 2001-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 37648
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175901.pdf
[firstpage_image] =>[orig_patent_app_number] => 09940316
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/940316 | Polynucleotides encoding the fkbA gene of the FK-520 polyketide synthase gene cluster | Aug 26, 2001 | Issued |
Array
(
[id] => 6693178
[patent_doc_number] => 20030040610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Method for preparing salts of polyene macrolide esters'
[patent_app_type] => new
[patent_app_number] => 09/935347
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3418
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040610.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935347
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935347 | Method for preparing salts of polyene macrolide esters | Aug 22, 2001 | Issued |
Array
(
[id] => 4554996
[patent_doc_number] => 07820803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Immobilized phosphatidic acid probe'
[patent_app_type] => utility
[patent_app_number] => 10/362571
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24832
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820803.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362571 | Immobilized phosphatidic acid probe | Aug 22, 2001 | Issued |
| 09/913669 | Cerebrovascular regeneration/recontruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenosid rb1 | Aug 15, 2001 | Abandoned |
Array
(
[id] => 6623777
[patent_doc_number] => 20020016301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Azithromycin combination for emesis control in mammals'
[patent_app_type] => new
[patent_app_number] => 09/929899
[patent_app_country] => US
[patent_app_date] => 2001-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5423
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016301.pdf
[firstpage_image] =>[orig_patent_app_number] => 09929899
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/929899 | Azithromycin combination for emesis control in mammals | Aug 14, 2001 | Abandoned |
| 09/720841 | Polyketides and their synthesis | Aug 12, 2001 | Abandoned |
Array
(
[id] => 6131626
[patent_doc_number] => 20020077350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2'
[patent_app_type] => new
[patent_app_number] => 09/919510
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15265
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077350.pdf
[firstpage_image] =>[orig_patent_app_number] => 09919510
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/919510 | Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2 | Jul 30, 2001 | Abandoned |
Array
(
[id] => 7436385
[patent_doc_number] => 20040002477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/333242
[patent_app_country] => US
[patent_app_date] => 2003-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2364
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002477.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333242
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333242 | Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient | Jul 29, 2001 | Issued |
Array
(
[id] => 7964257
[patent_doc_number] => 06680299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-20
[patent_title] => '4\'-substituted leucomycins'
[patent_app_type] => B2
[patent_app_number] => 09/917107
[patent_app_country] => US
[patent_app_date] => 2001-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12731
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680299.pdf
[firstpage_image] =>[orig_patent_app_number] => 09917107
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/917107 | 4'-substituted leucomycins | Jul 26, 2001 | Issued |
Array
(
[id] => 6131337
[patent_doc_number] => 20020077300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Screening method for cancer therapeutics and stable antitumor drug'
[patent_app_type] => new
[patent_app_number] => 09/916233
[patent_app_country] => US
[patent_app_date] => 2001-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4619
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077300.pdf
[firstpage_image] =>[orig_patent_app_number] => 09916233
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/916233 | Screening method for cancer therapeutics and stable antitumor drug | Jul 24, 2001 | Issued |
Array
(
[id] => 6343938
[patent_doc_number] => 20020035089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Orlistat compositions'
[patent_app_type] => new
[patent_app_number] => 09/912957
[patent_app_country] => US
[patent_app_date] => 2001-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7129
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035089.pdf
[firstpage_image] =>[orig_patent_app_number] => 09912957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/912957 | Method of reducing gastrointestinal side effects associated with orlistat treatment | Jul 24, 2001 | Issued |
Array
(
[id] => 6693062
[patent_doc_number] => 20030040494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Application of water and organic solvent soluble invermectin for topical and oral use'
[patent_app_type] => new
[patent_app_number] => 09/910076
[patent_app_country] => US
[patent_app_date] => 2001-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3146
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910076
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910076 | Application of water and organic solvent soluble ivermectin for topical and oral use | Jul 22, 2001 | Issued |